Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Apr 1, 2026 - 03:00
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.